Inhibition of CD95/CD95L (FAS/FASLG) Signaling with APG101 Prevents Invasion and Enhances Radiation Therapy for Glioblastoma-Reference-Cited by-同舟云学术

Inhibition of CD95/CD95L (FAS/FASLG) Signaling with APG101 Prevents Invasion and Enhances Radiation Therapy for Glioblastoma

Published:2018-02-16 Issue:5 Volume:16 Page:767-776
ISSN:1541-7786
Container-title:Molecular Cancer Research
language:en
Short-container-title:Mol Cancer Res

Author:

Blaes Jonas,Thomé Carina M.,Pfenning Philipp-Niclas,Rübmann Petra,Sahm Felix,Wick Antje,Bunse Theresa,Schmenger Torsten,Sykora Jaromir,von Deimling Andreas,Wiestler Benedikt,Merz Christian,Jugold Manfred,Haberkorn Uwe,Abdollahi Amir,Debus Jürgen,Gieffers Christian,Kunz Claudia,Bendszus Martin,Kluge Michael,Platten Michael,Fricke Harald,Wick Wolfgang,Lemke Dieter

Funder

Apogenix AG, Heidelberg; Germany

NCT 3.0 program

German Cancer Aid (N2M2)

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology,Molecular Biology

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LINC01410 accelerates the invasion of trophoblast cells by modulating METTL3/Fas;Molecular Biology Reports;2024-08-08

2. Integrative analysis of genomic and epigenomic regulation reveals miRNA mediated tumor heterogeneity and immune evasion in lower grade glioma;Communications Biology;2024-07-06

3. Treatment with the apoptosis inhibitor Asunercept reduces clone sizes in patients with lower risk Myelodysplastic Neoplasms;Annals of Hematology;2024-02-27

4. CAN008 prolongs overall survival in patients with newly diagnosed GBM characterized by high tumor mutational burden;Biomedical Journal;2023-09

5. Advances in molecular targeted therapies to increase efficacy of (chemo)radiation therapy;Strahlentherapie und Onkologie;2023-04-11